Feedback / Questions
rezpegaldesleukin (NKTR-358) - Nektar Therap
https://www.streetinsider.com/Corporate+News/Nektar+Therapeutics+%28NKTR%29%3A+REZOLVE-AD+Phase+2b+Study+of+Rezpegaldesleukin+Meets+Primary+and+Key+Secondary+Endpoints+in+Patients+with+Moderate-to-Severe+AD/24967791.html
Jun 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next